Work

The Role of Grp170 in SP-C Δexon4 ERAD

Year: 2010
Type: article
Abstract: Interstitial lung disease (ILD) encompasses a wide range of disorders that impairs gas exchange through thickening of the lung interstitium in children and adults.Mutations in the gene SFTPC encoding surfactant protein C (SP-C) are associated with development of ILD in children and adults.The mutations can result in misfolding of mutant SP-C with the potential to form cytotoxic aggregates.Thus to prevent aggregation, mutant SP-C is directed to the endoplasmic reticulum-associated degradation (ERAD) pathway for rapid removal from the ER and degradation by the proteasome in the cytosol.Glycoprotein ERAD is well characterized; however SP-C is non-glycosylated and cleared by the poorly characterized non-glycosylated ERAD pathway.Binding immunoglobulin protein (BiP), ERdj4 and ERdj5 were discovered to function as chaperones for ERAD of mutant SP-C.BiP ATPase activity is suggested to play a central role in ERAD of mutant SP-C.J-domain proteins ERdj4 and ERdj5 direct binding of BiP to misfolded substrate by enhancing BiP ATPase activity.Only regeneration of ATP bound BiP will execute release of misfolded substrate for dislocation and degradation; this essential step requires a nucleotide exchange factor (NEF).We hypothesize that the NEF glucose regulated protein 170 (Grp170) best serves mutant SP-C ERAD through localization to non-glycosylated ERAD components by the substrate binding domain (SBD) and mediating BiP release through the Grp170 nucleotide binding domain (NBD).
Author: Amer Jameel
Language: English
Subfield: Cell Biology
Open Access status: green
OpenAlex ID: W2597333649
FWCI:
Cites: 87
Cited by:
Related to: 9